Separation of the Pharmacokinetic/Pharmacodynamic Properties of Oral and IV Adinazolam Mesylate and N-Desmethyladinazolam Mesylate in Healthy Volunteers
- 1 April 1992
- journal article
- Published by Springer Science and Business Media LLC in Clinical Drug Investigation
- Vol. 4 (2), 155-165
- https://doi.org/10.1007/bf03258394
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate following single intravenous infusions of each compound in healthy volunteersEuropean Journal of Clinical Pharmacology, 1992
- Adinazolam sustained release formulation in the treatment of generalized anxiety disorderJournal of Anxiety Disorders, 1990
- Pharmacodynamics of Triazolam After Intravenous AdministrationThe Journal of Clinical Pharmacology, 1987
- Adinazolam???A New AntidepressantJournal of Clinical Psychopharmacology, 1987
- The effect of proadifen on the metabolism of adinazolamJournal of Pharmacy and Pharmacology, 1986
- Determination of biological activity of adinazolam and its metabolitesJournal of Pharmacy and Pharmacology, 1984
- Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepineEuropean Journal of Pharmacology, 1984
- Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepineNeuropharmacology, 1983
- Drug metabolite kineticsPharmacology & Therapeutics, 1981
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978